Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
European Journal of Clinical Pharmacology
|
June 15, 2000
QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience
F De Ponti, E Poluzzi, N Montanaro
European Journal of Clinical Pharmacology
|
August 11, 2001
Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus
F De Ponti, E Poluzzi, N Montanaro
Acta Diabetologica
|
October 20, 2011
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database
E Raschi, C Piccinni, E Poluzzi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
April 13, 2016
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System
E Raschi, E Poluzzi, A Koci, et al.
Alimentary Pharmacology & Therapeutics
|
February 12, 2004
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics
M Tonini, L Cipollina, E Poluzzi, et al.
Italian Journal of Pediatrics
|
April 18, 2017
Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit
A Girardi, S Galletti, E Raschi, et al.
European Journal of Clinical Pharmacology
|
April 17, 2002
Use of anti-asthmatic drugs in Italy: analysis of prescriptions in general practice in the light of guidelines for asthma treatment
E Poluzzi, D Resi, P Zuccheri, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
April 8, 2018
Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems
E Raschi, E Poluzzi, F Salvo, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
November 28, 2017
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems
E Raschi, M Parisotto, E Forcesi, et al.
Cephalalgia : an International Journal of Headache
|
September 24, 2014
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies
G Roberto, E Raschi, C Piccinni, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
European Journal of Clinical Pharmacology
|
June 15, 2000
QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience
F De Ponti, E Poluzzi, N Montanaro
European Journal of Clinical Pharmacology
|
August 11, 2001
Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus
F De Ponti, E Poluzzi, N Montanaro
Acta Diabetologica
|
October 20, 2011
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database
E Raschi, C Piccinni, E Poluzzi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
April 13, 2016
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System
E Raschi, E Poluzzi, A Koci, et al.
Alimentary Pharmacology & Therapeutics
|
February 12, 2004
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics
M Tonini, L Cipollina, E Poluzzi, et al.
Italian Journal of Pediatrics
|
April 18, 2017
Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit
A Girardi, S Galletti, E Raschi, et al.
European Journal of Clinical Pharmacology
|
April 17, 2002
Use of anti-asthmatic drugs in Italy: analysis of prescriptions in general practice in the light of guidelines for asthma treatment
E Poluzzi, D Resi, P Zuccheri, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
April 8, 2018
Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems
E Raschi, E Poluzzi, F Salvo, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
November 28, 2017
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems
E Raschi, M Parisotto, E Forcesi, et al.
Cephalalgia : an International Journal of Headache
|
September 24, 2014
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies
G Roberto, E Raschi, C Piccinni, et al.
Page
of 2